The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Metastatic Prostate Carcinoma Presenting as a Superscan on 68Ga-PSMA PET/CT
Abstract
We describe the finding of a metastatic superscan detected by Ga-PSMA PET/CT imaging. A 63-year-old man with metastatic prostate carcinoma underwent Ga-PSMA PET/CT imaging for staging and evaluation of the most appropriate therapeutic option. Images demonstrated diffuse and extensive skeletal uptake in the axial and appendicular skeleton, corresponding to the typical red marrow distribution. Intense soft tissue uptake was also seen in the prostate and multiple pelvic and abdominal lymph nodes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This scenario is common for many RPTs agents, and perhaps most prominently for prostate cancer ( 39 , 40 ), where metastatic dissemination is coincident with the marrow.”
From Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the Unknowns (2021) · cites this paper as [40]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients
Bubendorf, L., Schöpfer, A., Wagner, U., Sauter, G., Moch, H., Willi, N., Gasser, T. C., & Mihatsch, M. J. (2000) · Human Pathology · doi:10.1053/hp.2000.6698 · Cited by 1,895
Afshar‐Oromieh, A., Zechmann, C. M., Malcher, A., Eder, M., Eisenhut, M., Linhart, H., Holland‐Letz, T., Hadaschik, B. A., Giesel, F. L., Debus, J., et al. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2525-5 · Cited by 920
Mannweiler, S., Amersdorfer, P., Trajanoski, S., Terrett, J. A., King, D., & Méhes, G. (2008) · Pathology & Oncology Research · doi:10.1007/s12253-008-9104-2 · Cited by 386
The evolving biology and treatment of prostate cancer
Taichman, R. S., Loberg, R. D., Mehra, R., & Pienta, K. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31791 · Cited by 146
Mittal, B., Kamaleshwaran, K., Harisankar, C. N. B., Bhattacharya, A., Singh, S., & Mandal, A. (2012) · Indian Journal of Nuclear Medicine · doi:10.4103/0972-3919.110683 · Cited by 36
18F-FDG PET/CT Superscan in Prostate Cancer
Bailly, M., Besse, H., Kerdraon, R., Metrard, G., & Gauvain, S. (2014) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000000376 · Cited by 17
Afshar‐Oromieh, A., Malcher, A., Eder, M., Eisenhut, M., Linhart, H., Hadaschik, B. A., Holland‐Letz, T., Giesel, F. L., Kratochwil, C., Haufe, S., et al. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2378-y · Cited by 17
Lin, C., Chen, Y., Chang, C., Yang, W., Huang, C., & Hou, M. (2012) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/j.kjms.2012.08.038 · Cited by 12
Cited by
Ultra‐small superparamagnetic iron oxides for metastatic lymph node detection: back on the block
Fortuin, A. S., Brüggemann, R. J. M., van der Linden, J., Panfilov, I., Israël, B., Scheenen, T. W. J., & Barentsz, J. O. (2017) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1471 · Cited by 103
Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the Unknowns
Wahl, R. L., Sgouros, G., Iravani, A., Jacene, H., Pryma, D., Saboury, B., Capala, J., & Graves, S. A. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.262751 · Cited by 95
Pillai, M. R. A., Nanabala, R., Joy, A., Sasikumar, A., & Knapp, F. F. (2016) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2016.08.006 · Cited by 77
Lawal, I. O., Ankrah, A. O., Mokgoro, N. P., Vorster, M., Maes, A., & Sathekge, M. M. (2017) · The Prostate · doi:10.1002/pros.23379 · Cited by 74
Gourni, E., & Henriksen, G. (2017) · Molecules · doi:10.3390/molecules22040523 · Cited by 74
Zacho, H. D., Nielsen, J. B., Haberkorn, U., Stenholt, L., & Petersen, L. J. (2017) · Clinical Physiology and Functional Imaging · doi:10.1111/cpf.12480 · Cited by 69
Lawal, I. O., Morgenstern, A., Vorster, M., Knoesen, O., Mahapane, J., Hlongwa, K., Maserumule, L. C., Ndlovu, H., Reed, J., Popoola, G. O., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05778-w · Cited by 64
Global experience with PSMA-based alpha therapy in prostate cancer
Sathekge, M. M., Bruchertseifer, F., Vorster, M., Morgenstern, A., & Lawal, I. O. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-021-05434-9 · Cited by 59
The Role of PET and SPECT Imaging in Prostate Cancer Targeted Alpha Therapy: When and How?
Frantellizzi, V., Ricci, M., Cimini, A., Filippi, L., Conte, M., Feo, M. S. D., & VINCENTIS, G. D. (2023) · Applied Sciences · doi:10.3390/app13031890 · Cited by 13
Highlighting New Research Trends on Zirconium-89 Radiopharmaceuticals Beyond Antibodies
Duvenhage, J., Kahts, M., Summers, B., Zeevaart, J. R., & Ebenhan, T. (2024) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2024.10.003 · Cited by 13
Schlenkhoff, C. D., Gaertner, F. C., Essler, M., Hauser, S., & Ahmadzadehfar, H. (2016) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001158 · Cited by 10
Chan, M., & Schembri, G. P. (2016) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001499 · Cited by 9
Skeletal “Superscan” on 18F-Choline PET/CT
Dias, A. H., & Bouchelouche, K. (2015) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000001080 · Cited by 9
Tripathi, M., Agarwal, K. K., Kumar, R., & Ba, C. (2016) · Indian Journal of Nuclear Medicine · doi:10.4103/0972-3919.178330 · Cited by 8
Renal osteodystrophy presenting as a metabolic superscan on F-18 FDG PET/CT
Lawal, I. O., Ankrah, A. O., Ololade, K., Modiselle, M., & Sathekge, M. M. (2017) · Medicine · doi:10.1097/md.0000000000008471 · Cited by 5
Radiotheranostics in Low- and Middle-Income Countries: Challenges, Practice, and Prospects
Lawal, I. O., Ndlovu, H., Kabunda, J., Mokoala, K. M. G., & Sathekge, M. M. (2025) · World Journal of Nuclear Medicine · doi:10.1055/s-0045-1812307 · Cited by 2
Superscan on 68Ga PSMA PET/CT in patients with metastatic prostate carcinoma: A case series
Fundacion Universitaria Sanitas, B., Galindo-Cortés, D. F., Efeer, H. M., Fundacion Universitaria Sanitas, B., Perdomo, S. C., & Instituto Nacional de Cancerologia, B. (2023) · Archive of Clinical Cases · doi:10.22551/2023.41.1004.10267 · Cited by 1
Shumilina, N. Y., Vyazmin, V. V., Evdokimova, E. Y., Dashanov, D. O., Chanchikova, N. G., & Zukov, R. A. (2020) · Siberian Journal of Oncology · doi:10.21294/1814-4861-2020-19-2-17-24 · Cited by 1
Paquet, E., Jung, M., Kryza, D., Pretet, V., Fléchon, A., & Giraudet, A. (2023) · Médecine Nucléaire · doi:10.1016/j.mednuc.2023.09.007
Therapy of Castration-Resistant Prostate Cancer: Where Is the Place of 225Ac-PSMA?
Lawal, I. O., Morgenstern, A., Knoesen, O., Vorster, M., Bruchertseifer, F., & Sathekge, M. M. (2024) · Springer eBooks · doi:10.1007/978-3-031-33533-4_26
Metadata
- Authors
- Lawal, I., Vorster, M., Boshomane, T., Ololade, K., Ebenhan, T., & Sathekge, M.
- Affiliations
- Steve Biko Hospital (ZA)
- Corresponding author
- Sathekge, Mike
- Venue
- Clinical Nuclear Medicine
- Published
- 2015-09
- Volume
- 40
- Issue
- 9
- Pages
- 755-756
- ISSN
- 0363-9762 (ISSN-L)
- OpenAlex
- W570668398
- Cited by
- 20
- References
- 8
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 2 · 2020: 1 · 2017: 5 · 2016: 4 · 2015: 1
- FWCI
- 2.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Nuclear Medicine (publishedVersion)
- PubMed (publishedVersion)
- UpSpace Institutional Repository (University of Pretoria) (submittedVersion)
- Topics
- Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiopharmaceutical Chemistry and Applications
- Keywords
- metastatic prostate cancer, 68Ga-PSMA PET/CT, superscan, bone metastasis, lymph node metastasis, prostate cancer staging
- MeSH terms
- Aged, Carcinoma, Edetic Acid, Gallium Isotopes, Gallium Radioisotopes, Humans, Lymphatic Metastasis, Male, Oligopeptides, Prostatic Neoplasms, Tomography, X-Ray Computed, Radiopharmaceuticals, Positron-Emission Tomography, Multimodal Imaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
